Table 2.

Clinicopathological features and PATZ1 expression of 52 pediatric gliomas.¹

Patient	Gender 2	Age (months)	Site 3	Subtype	Metastases	PATZ1
1	M	49	ch	LGG	NO	50%
2	F	38	ch	LGG	NO	5%
3	F	6	ch	LGG	NO	10%
4	F	102	ch	LGG	NO	5%
5	F	45	ch	LGG	NO	5%
6	F	12	ch	LGG	NO	20%
7	F	93	ch	LGG	NO	20%
8	F	33	ch	LGG	NO	20%
9	F	14	ch	LGG	NO	40%
10	F	88	pv	LGG	NO	60%
11	F	14	ch	LGG	NO	0
12	F	144	pv	LGG	NO	0
13	F	23	ch	LGG	NO	0
14	F	28	ch	LGG	NO	0
15	M	57	ch	LGG	NO	10
16	M	57	ch	LGG	NO	10
17	M	77	ch	LGG	NO	5
18	M	33	ch	LGG	NO	25
19	M	180	pv	LGG	NO	30
20	M	12	ch	LGG	NO	40
21	M	7	ch	LGG	NO	55
22	M	44	pv	LGG	NO	0
23	F	65	co	LGG	NO	0
24	F	9	pv	LGG	NO	0
25	F	171	th	HGG	YES	20
26	F	87	ch	HGG	YES	50
27	F	140	tr	HGG	YES	30
28	F	152	co	HGG	YES	0
29	M	119	tr	HGG	YES	50
30	M	52	th	HGG	YES	20
31	F	109	tr	HGG	NO	30
32	F	121	th	HGG	NO	40
33	F	149	co	HGG	NO	20
34	F	125	co	HGG	NO	40
35	F	143	tr	HGG	NO	80
36	F	164	th	HGG	NO	0
37	M	192	th	HGG	NO	5
38	M	153	tr	HGG	NO	5
39	M	101	co	HGG	NO	5
40	M	76	pv	HGG	NO	5
41	M	89	th	HGG	NO	5
42	M	56	th	HGG	NO	40
43	M	108	tr	HGG	NO	30
44	M	96	co	HGG	NO	40
45	M	139	co	HGG	NO	30
46	M	68	tr	HGG	NO	90
47	M	65	tr	HGG	NO	70
48	M	40	co	HGG	NO	55
49	M	126	co	HGG	NO	0
50	M	91	th	HGG	NO	0
51	M	82	tr	HGG	NO	0
52	M	148	co	HGG	NO	0

¹ Local cohort analyzed by immunohistochemistry. ² M, male; F, female. ³ ch, chiasma; pv, posterior ventricle; co, cortex; ta, thalamus; tr, trunk.